Transient paroxysmal dystonia in an infant possibly induced by cisapride

Italian Journal of Neurological Sciences

Volumn 17, Issue 2, 1996, Pages 157-159

  Angelini, L ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

cisapride; drug induced movement disorder; infancy; transient paroxysmal dystonia

Indexed keywords

CISAPRIDE;

ARTICLE; CASE REPORT; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INFANT;

CISAPRIDE; DYSTONIA; FEMALE; HUMANS; INFANT; PIPERIDINES; PROGNOSIS;

EID: 0029894711     PISSN: 03920461     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02000848     Document Type: Article

References (18)

1. rd Triennal Meeting Capo Boi 10-13 giugno 1989, Abstract Book, pp. 7.
2. ANGELINI L., RUMI V., LAMPERTI E., NARDOCCI N.: Transient paroxysmal dystonia in infancy. Neuropediatrics 19: 171-174, 1988.
3. BENLOUCIF S., KEEGAN M.J., GALLOWAY M.P.: Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J. Pharmacol. Exp. Ther. 265: 373-377, 1993.
4. BOCKAERT J., FOZARD J.R., DUMULIS A., CLARKE D.E.:The 5-HT4 receptor: a place in the sun. Trends Pharmacol. Sei. 13: 141-145, 1992.
5. CASTEELS-VAN DAELE M., VAN DE SCHUEREN P., ZIMMERMANN A., VAN DEN BON P.: Dystönie reactions in children caused by metoclopramide. Arch. Dis. Child. 45: 130-133, 1970.
6. DAVSON H.: The blood brain barrier. In: Bourne G.H. (Eds.), The structure and function of nervous tissue. New York and London: Academic Press, vol. 4, pp. 321-445, 1972.
7. DUMULIS A., SEBBEN M., BOCKAERT J.: The gastrointestinal prokinetic benzamide dérivâtes are agonist at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons. Naunyn-Schmiedeberg's Arch. Pharmacol. 340: 403-410, 1989.
8. EMERIT M.B., RIAD M., FATACCINI C.M., HAMON M.: Characteristics of [uC]Guanidinium accumulation in NG 108-15 cells exposed to serotonin 5-HT3 receptor ligands and substance. P. J. Neurochem. 60: 2059-2067, 1993.
9. FEHR H.F.: Risk factors, co-medication, and concomitant diseases: their influence on the outcome of theraphy with cisapride. Scand. J. Gastroenterol. Suppl. 195: 40-46, 1993.
10. FLYNN D.L., ZABROWSKI D.L., BECKER D.P. et al.: SC53116: the first selective agonist at the newly identified serotonine 5-HT4 receptor subtype. J. Med. Chem. 35: 1489-1491, 1992.
11. GRAYBIEL A.M., NEWMAN-GAGE H.: Ontogeny of dopaminergic and cholinergic systems in the basal ganglia. In: L. Angelini, G. Lanzi, U. Balottin, N. Nardocci (Eds.), Extrapyramidal Disorders in Childhood. Amsterdam Excerpta Medica pp. 1-10, 1987.
12. KILPATRICK G.J., ROGERS H.: 5-HT^ receptors. In: P.M. Vanhoutte P.M. et al. (Eds.), Serotonin from cell biology to pharmacology and therapeutics. Netherlands, Klüver Academic Publishers and Fondazione Giovanni Lorenzini pp. 99-106, 1993.
13. KINSBOURNE M.: Hiatus hernia with contorsion of the neck. Lancet 1: 1058, 1964.
14. MEGENS A.A., AWOUTERS F.H., NIEMEGEERS C.J.: General pharmacology of the four gastrointestinal motility stimulants bethanechol, metcolopramide, trimebutine and cisapride. Arzneimittelforschung 41: 631-634, 1991.
15. MiCHELis M., MONBALIU J., HENRIKS R. et al.: Pharmacokinetics and tissue distribution of the new gastrokinetic agent cisapride in rat, rabbit and dog. Arzneimittelforschung 37: 1159-1167, 1987.
16. SEMENOVA T.P., TICKU M.K.: Effects of 5-HT receptor antagonists on seizure susceptibility and locomotor activity in DBA/2 mice. Brain Res. 588: 229-236, 1992.
17. STEWARD L.J., BAMES N.M.: The 5-HT4 receptor agonists renzapride and (S)-zacopride stimulate dopamine release from rat striatal slices. Proc. British Pharmacol. Soc. 14-16 September, 1993; P9.
18. WAEBER C, SEBBEN M., GROSSMAN C., JAVOY-AGID F., BOCKAERT J., DUMULIS A.: pH]-GR113808 labels 5-HT4 receptors in the human and guinea-pig brain. Neuroreport 4: 1239-1242, 1993.